Val-d'Or District Gold Miner Posts Encouraging Assay Results
  (1/28/22)
Troilus Gold Corp. released drill results from eight new holes at its Troilus property. A mining analyst at Laurentian Bank Securities Equity Research commented in a research note that the results appear to confirm that the Southwest Zone is the project's "Center of Gravity". More >

Co. Meets Goals in COVID Drug Trial
Source: Streetwise Reports  (1/28/22)
Todos Medical has closed a Phase 2 trial of its antiviral 3CL protease inhibitor Tollovir after getting positive interim data. More >

FDA Approves First Tubeless Insulin Delivery Device
Source: Streetwise Reports  (1/28/22)
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone. More >

Developer of Smart Glass Tech Signs Supply Agreement With REIT
  (1/27/22)
This agreement, which could lead to Crown Electrokinetics providing its Smart Window inserts to Hudson Pacific Properties, could represent about a $100 million opportunity for the tech firm, noted a Dawson James Securities Inc. report. More >

This Junior Miner Is Looking for Big Gold
Source: The Critical Investor  (1/27/22)
The Critical Investor is looking into Aztec Minerals, which is aiming to delineate two oxide deposits in Mexico and Arizona, both with large scale porphyry/CRD potential at depth. More >

Hard Drive Maker Posts 18% YoY Growth in Q2 Revenue
Source: Streetwise Reports  (1/27/22)
Shares of hard drive storage maker Seagate Technology Holdings Plc. traded 8% higher after the company reported Q2/22 financial results that featured 39% YoY increase in free cash flow. More >

Read Why These 3 Institutions Like This Water Tech Co.
Source: Streetwise Reports  (1/26/22)
Forward Water Technologies Corp. is exploring applications for its forward osmosis water technology in the lithium extraction industry. More >

REIT Likely to Buy Product From Smart Glass Tech Firm
  (1/26/22)
The master supply agreement between Crown Electrokinetics and Hudson Pacific Properties is likely a precursor to purchase orders being placed in 2022, noted a ROTH Capital Partners report. More >

Materials Science Co. Posts Strong Sales Gains in All 5 of its Business Segments
Source: Streetwise Reports  (1/26/22)
Corning Inc. shares traded 11% higher after the company reported Q4/21 and FY/21 financial results highlighting a 23% YoY increase in core sales. More >

Fiji Gold Project Returns 'Multiple Bonanza Grade Intercepts'
Source: Streetwise Reports  (1/25/22)
Lion One Metals' infill drilling at its Tuvatu gold project in Fiji, in an area earmarked for early production, has defined "exceptionally high-grade mineralization." More >

Barsele Takes Another Swing at Agnico Ownership Stake
Source: Streetwise Reports  (1/25/22)
Vancouver-based junior Barsele Minerals Corp. is taking the rare step of trying to buy out its major partner, Agnico Eagle Mines Ltd. More >

Possible Treatment for CRC Shows Promise
  (1/25/22)
New trial results of Exelixis' cabozantinib in colorectal cancer are encouraging for further development of the biopharma's XL902 in the indication, noted an H.C. Wainwright & Co. report. More >

'Excellent Drilling Results Out Today' by Fiji Explorer
Source: Clive Maund  (1/25/22)
Technical Analyst Clive Maund dissects Lion One's stock chart and explains why he sees this to be a "great buy spot" for the company's stock. More >

Copper Mining Co. Trading at a Discount
  (1/25/22)
Coverage was initiated on World Copper, which has Q1/22 catalysts and 2022 exploration plans for all three of its properties, noted a Fundamental Research Corp. report. More >

Co. Looks to New Structures of Psychedelic Drug for Strokes
Source: Streetwise Reports  (1/25/22)
Algernon Pharmaceuticals Inc. has included novel salt forms of a psychedelic drug being investigated to combat strokes in its intellectual property applications. More >

Crossfire: What Happens When Rising Bond Yields Meet Weakening Macroeconomic Data?
Source: Michael Ballanger  (1/25/22)
Michael Ballanger discusses whether gold and silver (and their equities) will decouple from correlation with the broad stock market. More >

Copper, Gold Mining Explorer to Go Public
Source: Streetwise Reports  (1/25/22)
Zacapa Resources will complete its initial public offering and be listed on the TSX Venture Exchange on Jan. 26. More >

Explorer of Metals to Start Drilling Soon
Source: Streetwise Reports  (1/25/22)
With this impending program, Newrange Gold will drill test priority targets at its North Birch and Argosy projects northeast of Ontario's Red Lake. More >

Bone Cancer Drug Meets Goals, Stocks Rise
Source: Streetwise Reports  (1/25/22)
Shares of Sierra Oncology Inc. traded 48% higher after the company reported that topline data obtained during its Pivotal Phase 3 MOMENTUM Myelofibrosis Study showed that its momelotinib produced statistically significant improvements in anemia and splenic size. More >

Reyna Gold Drilling Sonora for Gold in February, Now Trading
Source: Bob Moriarty  (1/25/22)
Bob Moriarty of 321 Gold explains why he is an investor in Reyna Gold, an explorer with projects in northern Mexico that began publicly trading earlier this month. More >

With New Shopping App, Users Watch Shows and Buy Goods
Source: Streetwise Reports  (1/24/22)
OOOOO Entertainment Commerce and QVC Italia debut likeQ, their new interactive livestream shopping app in Italy. More >

Mining Co. to Start Drilling at Chilean Asset Jan. 25
Source: Streetwise Reports  (1/24/22)
Red Metal Resources plans a 2,000 meter diamond drill plan, testing two sets of targets shown, via previous exploration efforts, to be prospective. More >

FDA Gives Fast Track Status to Firm for Adrenal Rescue Pen
  (1/24/22)
Now with fast track status and positive Phase 1 study results, Antares Pharma plans to advance its ATRS-1902 product candidate into a second trial in Q2/22, noted a Ladenburg Thalmann report. More >

Fourth COVID-19 Vaccine Shot Shown Less Effective
  (1/24/22)
BioNTech aims to develop a COVID-19 vaccine targeting the Omicron variant, noted an H.C. Wainwright & Co. report. More >

‘Strong Data’ Expected From Todos Medical Data Lock
Source: Vision and Value  (1/24/22)
Todos Medical is set to take on the dominant players in oral antivirals for mild to moderate COVID-19, Pfizer Inc. and Merck & Co. Inc., with "strong data" expected to be released soon for its drug Tollovir. More >